107 related articles for article (PubMed ID: 3090097)
1. The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist.
Dahl KD; Pavlou SN; Kovacs WJ; Hsueh AJ
J Clin Endocrinol Metab; 1986 Sep; 63(3):792-4. PubMed ID: 3090097
[TBL] [Abstract][Full Text] [Related]
2. The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women.
Kessel B; Dahl KD; Kazer RR; Liu CH; Rivier J; Vale W; Hsueh AJ; Yen SS
J Clin Endocrinol Metab; 1988 Feb; 66(2):361-6. PubMed ID: 3123512
[TBL] [Abstract][Full Text] [Related]
3. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
4. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
5. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
6. Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method.
Jia XC; Hsueh AJ
Endocrinology; 1986 Oct; 119(4):1570-7. PubMed ID: 2428600
[TBL] [Abstract][Full Text] [Related]
7. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
[TBL] [Abstract][Full Text] [Related]
9. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ
J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
[TBL] [Abstract][Full Text] [Related]
10. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
[TBL] [Abstract][Full Text] [Related]
11. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
[TBL] [Abstract][Full Text] [Related]
12. Serum bioactive follicle-stimulating hormone in men with idiopathic azoospermia and oligospermia.
Wang C; Dahl KD; Leung A; Chan SY; Hsueh AJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):629-33. PubMed ID: 3116028
[TBL] [Abstract][Full Text] [Related]
13. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
14. Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay.
Jia XC; Kessel B; Yen SS; Tucker EM; Hsueh AJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1243-9. PubMed ID: 3084537
[TBL] [Abstract][Full Text] [Related]
15. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
[TBL] [Abstract][Full Text] [Related]
16. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
[TBL] [Abstract][Full Text] [Related]
17. Testosterone stimulates pituitary and serum FSH in GnRH antagonist-suppressed rats.
Rea MA; Weinbauer GF; Marshall GR; Nieschlag E
Acta Endocrinol (Copenh); 1986 Dec; 113(4):487-92. PubMed ID: 3098017
[TBL] [Abstract][Full Text] [Related]
18. Serum bioactive and immunoreactive follicle stimulating hormone during chronic treatment with gonadotropin releasing hormone agonist in elderly men.
Matzkin H; Braf Z; Dekel N
Horm Metab Res; 1991 Feb; 23(2):76-80. PubMed ID: 1710593
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix).
Marshall LA; Fluker MR; Jaffe RB; Monroe SE
J Clin Endocrinol Metab; 1991 Apr; 72(4):927-33. PubMed ID: 2005220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
